SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0000950123-23-005917
Filing Date
2023-06-30
Accepted
2023-06-30 17:07:15
Documents
3

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 34517
2 GRAPHIC g241143g0630090252394.jpg GRAPHIC 1690
3 GRAPHIC g241143g0630091414823.jpg GRAPHIC 2736
  Complete submission text file 0000950123-23-005917.txt   41932
Mailing Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472 (857) 760-0900
Neumora Therapeutics, Inc. (Filer) CIK: 0001885522 (see all company filings)

IRS No.: 844367680 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2836 Biological Products, (No Diagnostic Substances)